[HTML][HTML] Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions
Major depressive disorder (MDD) is a debilitating illness characterized by neuroanatomical
and functional alterations in limbic structures, notably the prefrontal cortex (PFC), that can be …
and functional alterations in limbic structures, notably the prefrontal cortex (PFC), that can be …
The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis
The nucleus accumbens is a major input structure of the basal ganglia and integrates
information from cortical and limbic structures to mediate goal-directed behaviors. Chronic …
information from cortical and limbic structures to mediate goal-directed behaviors. Chronic …
From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology
A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
Cannabidiol, neuroprotection and neuropsychiatric disorders
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …
CB1 and CB2 receptor pharmacology
AC Howlett, ME Abood - Advances in Pharmacology, 2017 - Elsevier
The CB 1 and CB 2 cannabinoid receptors (CB 1 R, CB 2 R) are members of the G protein-
coupled receptor (GPCR) family that were identified over 20 years ago. CB 1 Rs and CB 2 …
coupled receptor (GPCR) family that were identified over 20 years ago. CB 1 Rs and CB 2 …
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2
RG Pertwee, AC Howlett, ME Abood… - Pharmacological …, 2010 - ASPET
There are at least two types of cannabinoid receptors (CB1 and CB2). Ligands activating
these G protein-coupled receptors (GPCRs) include the phytocannabinoid Δ9 …
these G protein-coupled receptors (GPCRs) include the phytocannabinoid Δ9 …
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
RG Pertwee - British journal of pharmacology, 2008 - Wiley Online Library
Cannabis sativa is the source of a unique set of compounds known collectively as plant
cannabinoids or phytocannabinoids. This review focuses on the manner with which three of …
cannabinoids or phytocannabinoids. This review focuses on the manner with which three of …
Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
M Hermanns‐Clausen, S Kneisel, B Szabo… - …, 2013 - Wiley Online Library
Aims Recently, several synthetic cannabinoids were identified in herbal mixtures consumed
as recreational drugs alternative to cannabis products. The aim was to characterize the …
as recreational drugs alternative to cannabis products. The aim was to characterize the …
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
A Vallée, Y Lecarpentier, R Guillevin… - Acta biochimica et …, 2017 - academic.oup.com
Alzheimer's disease (AD) is a neurodegenerative disease, in which the primary etiology
remains unknown. AD presents amyloid beta (Aβ) protein aggregation and neurofibrillary …
remains unknown. AD presents amyloid beta (Aβ) protein aggregation and neurofibrillary …
Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
R Spanagel - Dialogues in clinical neuroscience, 2020 - Taylor & Francis
The last decades have seen a major gain in understanding the action of cannabinoids and
the endocannabinoid system in reward processing and the development of addictive …
the endocannabinoid system in reward processing and the development of addictive …